MorphoSys AG buy Tomtheonecat
Start price
22.01.24
/
70%
€32.11
Target price
22.01.25
-
Performance (%)
108.50%
Price
10.05.24
€66.95
Summary
This prediction is currently active. The BUY prediction by Tomtheonecat for MorphoSys AG has seen massive gains of 108.50%. This prediction currently runs until 22.01.25. The prediction end date can be changed by Tomtheonecat at any time. Tomtheonecat has 70% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| MorphoSys AG | 0.300% | 0.300% |
| iShares Core DAX® | 4.094% | 3.543% |
| iShares Nasdaq 100 | 1.424% | 0.512% |
| iShares Nikkei 225® | -1.572% | -4.633% |
| iShares S&P 500 | 1.822% | 0.963% |
According to Tomtheonecat what are the pros and cons of MorphoSys AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Growths faster than the competition
Very Future proof/growth oriented business model
Cons
Comments by Tomtheonecat for this prediction
In the thread Morphosys AG diskutieren
Buy MorphoSys AG